Search hospitals
>
Massachusetts
>
Boston
Dana Farber Cancer Institute
Claim this profile
Boston, Massachusetts 02215
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Solid Tumors
Conducts research for Lung Cancer
Conducts research for Pancreatic Cancer
3428 reported clinical trials
268 medical researchers
Summary
Dana Farber Cancer Institute is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Solid Tumors, Lung Cancer, Pancreatic Cancer and other specialties. Dana Farber Cancer Institute is involved with conducting 3,428 clinical trials across 1,498 conditions. There are 268 research doctors associated with this hospital, such as Susan Chi, MD, Geoffrey I. Shapiro, Haeseong Park, MD, and Ryan Sullivan, MD.
Area of expertise
Cancer
Dana Farber Cancer Institute has run 570 trials for Cancer. Some of their research focus areas include:
Breast Cancer
Dana Farber Cancer Institute has run 542 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Susan Chi, MD
Dana-Farber Cancer Institute
6 years of reported clinical research
Geoffrey I. Shapiro
Dana-Farber Cancer Institute
8 years of reported clinical research
Haeseong Park, MD
Washington University School of Medicine
7 years of reported clinical research
Ryan Sullivan, MD
Massachusetts General Hospital
4 years of reported clinical research
Clinical Trials running at Dana Farber Cancer Institute
Breast Cancer
Ovarian Cancer
Prostate Cancer
Brain Tumor
Chronic Lymphocytic Leukemia
Lung Cancer
Melanoma
Multiple Myeloma
Lymphoma
Glioblastoma
Avelumab + Palbociclib/Hydroxychloroquine
for Breast Cancer
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are found to harbor disseminated tumor cells (DTCs) in the bone marrow after definitive surgery and standard adjuvant therapy.
Recruiting
3 awards
Phase 2
12 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Zanidatamab vs Trastuzumab
for Breast Cancer
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Dana Farber Cancer Institute?
Dana Farber Cancer Institute is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Solid Tumors, Lung Cancer, Pancreatic Cancer and other specialties. Dana Farber Cancer Institute is involved with conducting 3,428 clinical trials across 1,498 conditions. There are 268 research doctors associated with this hospital, such as Susan Chi, MD, Geoffrey I. Shapiro, Haeseong Park, MD, and Ryan Sullivan, MD.
Where is Dana Farber Cancer Institute located?
The Dana Farber Cancer Institute is situated at 450 Brookline Ave, Boston, MA 02215, within the Longwood Medical Area. For access from the north, utilize I-93, the Tobin Bridge (Route 1), and Route 28, directing towards Storrow Drive, then proceed for 1.5 miles. Follow the exit for Kenmore Square/Fenway, Route 1S, stay in the far left lane, and continue onto Boylston Street (outbound), then bear slight left onto Brookline Avenue, and turn left onto Jimmy Fund Way to find the parking garage entrance on the right.
Who should I call to ask about financial aid or insurance network?
**Dana Farber Cancer Institute Contact Information:** - **Patient Billing Solutions Team:** For general financial inquiries and assistance with the Patient Financial Assistance program, call 617-632-3795. - **Shapiro Center for Patients and Families:** For insurance and financial information questions, contact 617-632-3750. - **International Office:** Specialized support for international patients is available. - **Language Assistance:** Spanish-speaking patients can call 617-632-3673. For all other languages, please call 617-632-6366. **Address:** 450 Brookline Ave., Boston, MA 02215-5450.
What insurance does Dana Farber Cancer Institute accept?
The Dana Farber Cancer Institute accepts a wide range of insurance plans, such as Aetna, Allways Health Partners, AmeriHealth, Anthem, Cigna, Humana, Oscar, and UnitedHealthcare. It is now an in-network provider for the Boston Medical Center HealthNet Plan (BMCHP), catering to Massachusetts residents, including MassHealth members from marginalized communities, individuals with disabilities, and seniors. The hospital offers specialized services for international patients and financial counseling for uninsured or low-income individuals to explore coverage options.
What awards or recognition has Dana Farber Cancer Institute received?
The Dana-Farber Cancer Institute in Boston, Massachusetts, is renowned for its exceptional research and care in the field of cancer. It has been recognized as one of the most noteworthy companies and non-profits led by women in Massachusetts. Furthermore, 24 of its researchers have been acknowledged as Highly Cited Researchers, underscoring their significant global impact on cancer research.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.